Tag: Neuraxpharm Group
No posts to display
News
U.S. FDA approves Alvotech and Teva’s SELARSDI, biosimilar to Stelara
The U.S. Food and Drug Administration (FDA) has approved Alvotech and Teva Pharmaceuticals' SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®,...
Medincell enters into agreement with AbbVie to develop next-generation long-acting injectable therapies
Medincell has formed a collaboration with AbbVie to co-develop and commercialize up to six therapeutic products across multiple therapeutic areas and indications.
It will use...
ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year
ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, is delighted to announce that for the fourth consecutive year, it...
